196 related articles for article (PubMed ID: 11018850)
1. Vanishing bile duct syndrome in Hodgkin's disease: case report.
Rossini MS; Lorand-Metze I; Oliveira GB; Souza CA
Sao Paulo Med J; 2000 Sep; 118(5):154-7. PubMed ID: 11018850
[TBL] [Abstract][Full Text] [Related]
2. Vanishing bile duct syndrome: a rare cause of jaundice in Hodgkin's lymphoma.
Amer S; Muqeetadnan M; Rahman A; Nusrat S; Hassan S
Turk J Gastroenterol; 2013; 24(5):444-6. PubMed ID: 24557970
[TBL] [Abstract][Full Text] [Related]
3. Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma.
Hubscher SG; Lumley MA; Elias E
Hepatology; 1993 Jan; 17(1):70-7. PubMed ID: 7678577
[TBL] [Abstract][Full Text] [Related]
4. Vanishing bile duct syndrome in Hodgkin's lymphoma: A case report and literature review.
Bakhit M; McCarty TR; Park S; Njei B; Cho M; Karagozian R; Liapakis A
World J Gastroenterol; 2017 Jan; 23(2):366-372. PubMed ID: 28127210
[TBL] [Abstract][Full Text] [Related]
5. Cholestatic liver disease with ductopenia (vanishing bile duct syndrome) in Hodgkin's disease: report of a case.
Guliter S; Erdem O; Isik M; Yamac K; Uluoglu O
Tumori; 2004; 90(5):517-20. PubMed ID: 15656342
[TBL] [Abstract][Full Text] [Related]
6. Complete remission of paraneoplastic vanishing bile duct syndrome after the successful treatment of Hodgkin's lymphoma: a case report and review of the literature.
Rota Scalabrini D; Caravelli D; Carnevale Schianca F; D'Ambrosio L; Tolomeo F; Boccone P; Manca A; De Rosa G; Nuzzo A; Aglietta M; Grignani G
BMC Res Notes; 2014 Aug; 7():529. PubMed ID: 25125318
[TBL] [Abstract][Full Text] [Related]
7. Cholestasis secondary to Hodgkin's disease: report of 2 cases of vanishing bile duct syndrome.
de Medeiros BC; Lacerda MA; Telles JE; da Silva JA; de Medeiros CR
Haematologica; 1998 Nov; 83(11):1038-40. PubMed ID: 9864926
[TBL] [Abstract][Full Text] [Related]
8. Hodgkin's lymphoma-related vanishing bile duct syndrome: a case report and literature review.
Wong KM; Chang CS; Wu CC; Yin HL
Kaohsiung J Med Sci; 2013 Nov; 29(11):636-41. PubMed ID: 24183359
[TBL] [Abstract][Full Text] [Related]
9. Severe jaundice, due to vanishing bile duct syndrome, as presenting symptom of Hodgkin's lymphoma, fully reversible after chemotherapy.
Leeuwenburgh I; Lugtenburg EP; van Buuren HR; Zondervan PE; de Man RA
Eur J Gastroenterol Hepatol; 2008 Feb; 20(2):145-7. PubMed ID: 18188038
[TBL] [Abstract][Full Text] [Related]
10. Vanishing bile duct syndrome as a manifestation of Hodgkin's lymphoma: a case report and review of the literature.
Nader K; Mok S; Kalra A; Harb A; Schwarting R; Ferber A
Tumori; 2013; 99(4):e164-8. PubMed ID: 24326854
[TBL] [Abstract][Full Text] [Related]
11. [Spontaneous resolution of vanishing bile duct syndrome in Hodgkin's lymphoma].
Han WS; Jung ES; Kim YH; Kim CH; Park SC; Lee JY; Chang YJ; Yeon JE; Byun KS; Lee CH
Korean J Hepatol; 2005 Jun; 11(2):164-8. PubMed ID: 15980675
[TBL] [Abstract][Full Text] [Related]
12. Hodgkin's disease presenting as cholestatic hepatitis with prominent ductal injury.
Liangpunsakul S; Kwo P; Koukoulis GK
Eur J Gastroenterol Hepatol; 2002 Mar; 14(3):323-7. PubMed ID: 11953700
[TBL] [Abstract][Full Text] [Related]
13. [Involvement of the common bile duct in Hodgkin's disease : report of three cases (author's transl)].
Pariente D; Cornud F; Grenier P; Degos F; Nahum H
Sem Hop; 1981 Dec 18-25; 57(47-48):2027-30. PubMed ID: 6276986
[TBL] [Abstract][Full Text] [Related]
14. [Paraneoplastic vanishing bile duct syndrome in a case of Hodgkin's disease].
Allory Y; Métreau J; Zafrani E
Ann Pathol; 2000 Jan; 20(1):52-5. PubMed ID: 10648987
[TBL] [Abstract][Full Text] [Related]
15. [Ductal regeneration in vanishing bile duct syndrome in Hodgkin's lymphoma].
Córdoba Iturriagagoitia A; Iñarrairaegui Bastarrica M; Pérez de Equiza E; Zozaya Urmeneta JM; Martínez-Peñuela JM; Beloqui Pérez R
Gastroenterol Hepatol; 2005 May; 28(5):275-8. PubMed ID: 15871809
[TBL] [Abstract][Full Text] [Related]
16. Vanishing bile duct syndrome in a Hodgkin's lymphoma patient with fatal outcome despite lymphoma remission.
Aleem A; Al-Katari M; Alsaleh K; AlSwat K; Al-Sheikh A
Saudi J Gastroenterol; 2013; 19(6):286-9. PubMed ID: 24195983
[TBL] [Abstract][Full Text] [Related]
17. Hodgkin lymphoma associated vanishing bile duct syndrome treated successfully with a brentuximab based regimen.
Morgan JD; Weishar RC; Kwok RM; Lieuw KM
BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 37989332
[TBL] [Abstract][Full Text] [Related]
18. [Hodgkin’s lymphoma-related vanishing bile duct syndrome].
Boldizsár S; Rottek J; Schneider T; Varga F; Szaleczky E
Orv Hetil; 2021 May; 162(22):884-888. PubMed ID: 34052798
[TBL] [Abstract][Full Text] [Related]
19. Vanishing bile duct syndrome related to DILI and Hodgkin lymphoma overlap: A rare and severe case.
Greca RD; Cunha-Silva M; Costa LBE; Costa JGF; Mazo DFC; Sevá-Pereira T; Nascimento MMC; Pereira IE; Oliveira FC; Faria GAS; Neto FLP; Almeida JRS
Ann Hepatol; 2020; 19(1):107-112. PubMed ID: 31537508
[TBL] [Abstract][Full Text] [Related]
20. Brentuximab vedotin in combination with sequential procarbazine, cyclophosphamide and prednisolone for the management of Hodgkin's lymphoma-associated vanishing bile duct syndrome (VBDS) with severe obstructive liver failure.
Fong M; Boyle S; Gutta N
BMJ Case Rep; 2019 Feb; 12(2):. PubMed ID: 30796069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
